80 related articles for article (PubMed ID: 29871843)
1. Infection by Epstein-Barr virus in Fes (Morocco). Prevalence and predictors of positivity in nasopharyngeal cancer.
El-Amrani-Joutey M; Jiménez-García R; Linares-García-Valdecasas R; Palomar-Gallego MA; Jiménez-Trujillo I; López-de-Andrés A; Vázquez-Vázquez L
J Infect Public Health; 2018; 11(6):807-811. PubMed ID: 29871843
[TBL] [Abstract][Full Text] [Related]
2. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
[TBL] [Abstract][Full Text] [Related]
3. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.
Zhang B; Zong Y; He J; Zhong B; Lin S
Chin Med J (Engl); 2003 Jun; 116(6):913-7. PubMed ID: 12877806
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus in nasopharyngeal carcinoma in Indian patients.
Rathaur RG; Chitale AR; Banerjee K
Indian J Cancer; 1999; 36(2-4):80-90. PubMed ID: 10921211
[TBL] [Abstract][Full Text] [Related]
5. Human Cytomegalovirus and Epstein-Barr Virus Genotypes in Apical Periodontitis Lesions.
Jakovljevic A; Andric M; Knezevic A; Soldatovic I; Nikolic N; Karalic D; Milasin J
J Endod; 2015 Nov; 41(11):1847-51. PubMed ID: 26435468
[TBL] [Abstract][Full Text] [Related]
6. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
Tan EL; Peh SC; Sam CK
J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
[TBL] [Abstract][Full Text] [Related]
7. Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Northern China.
Cui Y; Wang Y; Liu X; Chao Y; Xing X; Zhao C; Liu C; Luo B
Intervirology; 2011; 54(3):131-8. PubMed ID: 20948223
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus strain characterisation in South African patients with nasopharyngeal carcinomas.
Janse van Rensburg E; van Heerden WF; Robson BA; Swart TJ; Engelbrecht S
Anticancer Res; 2000; 20(3B):1953-7. PubMed ID: 10928133
[TBL] [Abstract][Full Text] [Related]
9. Association of Epstein Barr Virus (EBV) with nasopharyngeal carcinoma (NPC).
Shah SH; Soomro IN; Haroon S; Moatter T
J Pak Med Assoc; 2000 Jun; 50(6):182-3. PubMed ID: 10979624
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
11. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma.
Li DJ; Bei JX; Mai SJ; Xu JF; Chen LZ; Zhang RH; Yu XJ; Hong MH; Zeng YX; Kang T
J Med Virol; 2009 Jul; 81(7):1253-60. PubMed ID: 19475622
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma.
Kumar S; Wairagkar NS; Mahanta J
Indian J Cancer; 2001; 38(2-4):72-5. PubMed ID: 12593442
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of Epstein-Barr virus infection in different types and sites of lymphomas.
Zhang Y; Peng J; Tang Y; He J; Peng J; Zhao Q; He R; Xie X; Peng X; Gan R
Jpn J Infect Dis; 2010 Mar; 63(2):132-5. PubMed ID: 20332578
[TBL] [Abstract][Full Text] [Related]
16. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.
Lin JC; Wang WY; Chen KY; Wei YH; Liang WM; Jan JS; Jiang RS
N Engl J Med; 2004 Jun; 350(24):2461-70. PubMed ID: 15190138
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Epstein-Barr virus-encoded small RNA gene variations in virus associated lymphomas in Northern China.
Zhao Z; Sun L; Liu S; Shu J; Luo B
Arch Virol; 2017 Jun; 162(6):1609-1616. PubMed ID: 28220325
[TBL] [Abstract][Full Text] [Related]
18. Polymerase chain reaction study of Epstein-Barr virus in high risk group of nasopharyngeal carcinoma: a preliminary report.
Luxamechanporn T; Neimhom S; Kunachak S; Kulapaditharom B
J Med Assoc Thai; 1999 Jun; 82(6):593-7. PubMed ID: 10443082
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two laboratory extraction techniques for the detection of Epstein-Barr virus in the saliva of nasopharyngeal carcinoma patients.
Shan J; Pow EH; Tsang PC; Perera RA; Kwong DL
J Investig Clin Dent; 2014 May; 5(2):104-8. PubMed ID: 24574317
[TBL] [Abstract][Full Text] [Related]
20. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
